| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 3 buys and 14 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $5.06M | - | |
| Other | 21.6K | $1.44M | - | |
| Other | 15.4K | $1.03M | -5,538 | |
| Dir | 8.0K | $533.5K | - | |
| Dir | 8.0K | $533.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2018 | Chess Robert84 | Director | Sell | 4,500 | $56.81 | $255,645.00 | -1.6% | |
| Sep 4, 2018 | Greer R Scott | Director | Sale+OE | 10,000 | $67.39 | $673,900.00 | -7.1% | |
| Aug 21, 2018 | Winger Dennis L | Director | Sale+OE | 30,000 | $59.96 | $1,798,800.00 | -26.0% | |
| Aug 14, 2018 | Winger Dennis L | Director | Sell | 34,250 | $60.60 | $2,075,378.75 | -25.0% | |
| Jun 27, 2018 | Robin Howard W58 | President &CEO | Sale+OE | 130,000 | $49.52 | $6,438,035.63 | -16.2% | |
| Jun 6, 2018 | Whitfield Roy A | Director | Buy | 5,000 | $58.04 | $290,212.00 | +1.0% | |
| Jun 6, 2018 | Greer R Scott | Director | Sale+OE | 10,000 | $60.28 | $602,786.00 | -3.7% | |
| Jun 5, 2018 | Chess Robert84 | Director | Sale+OE | 10,000 | $55.16 | $551,600.00 | -3.5% | |
| May 16, 2018 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sell | 3,576 | $83.39 | $298,202.64 | -5.2% | |
| May 16, 2018 | Robin Howard W58 | President &CEO | Sell | 12,791 | $83.39 | $1,066,641.49 | -5.4% |